Galapagos
Galapagos is an investment firm.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Galapagos is an investment firm.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2026 | Third Arc Bio | $52.0M Series A | Andreessen Horowitz | AbbVie, Aberdeen Investments, Alderline Group, Biotechnology Value Fund, Goldman Sachs Alternatives, Hillhouse Investment, Marshall Wace, Omega Funds, T. Rowe Price |